Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
Wegovy maker Novo sharpens consumer focus with board role for Mars CEO- Radiate brilliantly: The 5 Precious stone Rings to Purchase in 2024
- Misremembering might actually be a sign your memory is working optimally
- Cases of norovirus are on the rise just in time for the holiday season
- How to watch 'A Charlie Brown Christmas' for free this weekend
- Which '80s Film Actually Holds Up Today?
- Kremlin: Russian troops conquer Pokrovsk after year of intense combat
- Exclusive-Drugmakers raise US prices on 350 medicines despite pressure from Trump
- Mosquitoes carrying malaria are evolving more quickly than insecticides can kill them – researchers pinpoint how
